1. First‐in‐man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. (10th January 2013) Authors: Moehrle, Joerg J.; Duparc, Stephan; Siethoff, Christoph; van, Paul L. M.; Craft, J. Carl; Arbe‐Barnes, Sarah; Charman, Susan A.; Gutierrez, Maria; Wittlin, Sergio; Vennerstrom, Jonathan L. Journal: British journal of clinical pharmacology Issue: Volume 75:Number 2(2013:Feb.) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗